Mitochondrial Dysfunction in Polycystic Ovary Syndrome.

Area of Science:

• Genetics
• Endocrinology
• Mitochondrial Biology

Background:

• Polycystic ovary syndrome (PCOS) is a complex endocrine disorder with multiple contributing factors.
• Genetic elements, particularly mitochondrial DNA (mtDNA) variations, are emerging as significant contributors to PCOS etiology.
• PCOS is observed in syndromic and non-syndromic mitochondrial disorders, highlighting the role of mtDNA.

Purpose of the Study:

• To review the current evidence linking mitochondrial DNA (mtDNA) variations to the pathophysiology of polycystic ovary syndrome (PCOS).
• To explore the association of PCOS with both syndromic and non-syndromic mitochondrial disorders.
• To investigate the potential role of mtDNA variants exclusively affecting ovarian function in PCOS development.

Main Methods:

• Literature review of studies investigating genetic causes of PCOS.
• Analysis of reported cases of PCOS associated with mitochondrial disorders (e.g., MERRF syndrome).
• Examination of research on mtDNA point mutations and deletions in PCOS patients.
• Inclusion of evidence from animal studies on mitochondrial function in PCOS ovarian tissue.

Main Results:

• mtDNA variations are increasingly recognized as causative genetic factors in PCOS.
• PCOS is associated with syndromic mitochondrial disorders like MERRF and non-syndromic forms linked to insulin resistance.
• mtDNA variants exclusively impacting ovarian function have been reported in PCOS.
• Animal studies indicate impaired mitochondrial function, morphology, and biogenesis in the ovaries of PCOS patients.

Conclusions:

• There is substantial and growing evidence implicating mtDNA variants in the pathophysiology of PCOS.
• mtDNA variations represent a significant genetic contribution to the development of polycystic ovary syndrome.
• Further research is required to definitively establish the causal relationship between specific mtDNA variants and PCOS.